128 related articles for article (PubMed ID: 21095106)
1. Significant correlation of serum IL-22 levels with CCL17 levels in atopic dermatitis.
Hayashida S; Uchi H; Takeuchi S; Esaki H; Moroi Y; Furue M
J Dermatol Sci; 2011 Jan; 61(1):78-9. PubMed ID: 21095106
[No Abstract] [Full Text] [Related]
2. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
[TBL] [Abstract][Full Text] [Related]
3. Serum thymus and activation-regulated chemokine (TARC) and interleukin-31 levels as biomarkers for monitoring in adult atopic dermatitis.
Kyoya M; Kawakami T; Soma Y
J Dermatol Sci; 2014 Sep; 75(3):204-7. PubMed ID: 24984931
[No Abstract] [Full Text] [Related]
4. Serum TARC and CTACK concentrations in children with atopic dermatitis, allergic asthma, and urticaria.
Machura E; Rusek-Zychma M; Jachimowicz M; Wrzask M; Mazur B; Kasperska-Zajac A
Pediatr Allergy Immunol; 2012 May; 23(3):278-84. PubMed ID: 22017510
[TBL] [Abstract][Full Text] [Related]
5. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis.
Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K
Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603
[TBL] [Abstract][Full Text] [Related]
6. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
Hon KL; Lam MC; Leung TF; Wong KY; Chow CM; Fok TF; Ng PC
Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
[TBL] [Abstract][Full Text] [Related]
7. The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one of the factors involved in pathogenesis of atopic dermatitis.
Narbutt J; Lesiak A; Sysa-Jedrzeiowska A; Zakrzewski M; Bogaczewicz J; Stelmach I; Kuna P
Mediators Inflamm; 2009; 2009():269541. PubMed ID: 19639049
[TBL] [Abstract][Full Text] [Related]
8. EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients.
Thijs JL; Drylewicz J; Fiechter R; Strickland I; Sleeman MA; Herath A; May RD; Bruijnzeel-Koomen CAFM; Knol EF; Giovannone B; de Bruin-Weller MS; Nierkens S; Hijnen DJ
J Allergy Clin Immunol; 2017 Dec; 140(6):1703-1705. PubMed ID: 28823810
[No Abstract] [Full Text] [Related]
9. Immunoinflammatory Biomarkers in Serum Are Associated with Disease Severity in Atopic Dermatitis.
Holm JG; Hurault G; Agner T; Clausen ML; Kezic S; Tanaka RJ; Thomsen SF
Dermatology; 2021; 237(4):513-520. PubMed ID: 33730733
[TBL] [Abstract][Full Text] [Related]
10. Chemokine expression in diverse nonimmediate drug hypersensitivity reactions: focus on thymus activation-regulated chemokine, cutaneous T-cell-attracting chemokine, and interleukin-10.
Wang F; He D; Tang X; Zhang X
Ann Allergy Asthma Immunol; 2014 Aug; 113(2):204-8. PubMed ID: 24932689
[TBL] [Abstract][Full Text] [Related]
11. [Biomarker of atopic dermatits -focusing on serum TARC/CCL17 level as severity marker-].
Saeki H
Arerugi; 2013 Feb; 62(2):131-7. PubMed ID: 23531648
[No Abstract] [Full Text] [Related]
12. Variations in serum TARC and I-TAC levels reflect minor changes in disease activity and pruritus in atopic dermatitis.
Kimura T; Sugaya M; Suga H; Morimura S; Miyamoto A; Kai H; Kagami S; Yanaba K; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Acta Derm Venereol; 2014 May; 94(3):331-2. PubMed ID: 24104601
[No Abstract] [Full Text] [Related]
13. The Correlation of Serums CCL11, CCL17, CCL26, and CCL27 and Disease Severity in Patients with Urticaria.
Lu T; Jiao X; Si M; He P; Zou J; Zhang S; Zeng K
Dis Markers; 2016; 2016():1381760. PubMed ID: 27057079
[TBL] [Abstract][Full Text] [Related]
14. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
Furukawa H; Takahashi M; Nakamura K; Kaneko F
J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children.
Hon KL; Leung TF; Ma KC; Li AM; Wong Y; Fok TF
Clin Exp Dermatol; 2004 May; 29(3):293-6. PubMed ID: 15115514
[TBL] [Abstract][Full Text] [Related]
16. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
[TBL] [Abstract][Full Text] [Related]
17. Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis.
Song TW; Sohn MH; Kim ES; Kim KW; Kim KE
Clin Exp Allergy; 2006 Mar; 36(3):346-51. PubMed ID: 16499646
[TBL] [Abstract][Full Text] [Related]
18. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
Shimada Y; Takehara K; Sato S
J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
[TBL] [Abstract][Full Text] [Related]
19. Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS).
Furusyo N; Takeoka H; Toyoda K; Murata M; Maeda S; Ohnishi H; Fukiwake N; Uchi H; Furue M; Hayashi J
Eur J Dermatol; 2007; 17(5):397-404. PubMed ID: 17673383
[TBL] [Abstract][Full Text] [Related]
20. Effects of cyclosporine on pruritus and serum IL-31 levels in patients with atopic dermatitis.
Otsuka A; Tanioka M; Nakagawa Y; Honda T; Ikoma A; Miyachi Y; Kabashima K
Eur J Dermatol; 2011; 21(5):816-7. PubMed ID: 21727058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
